‹ ›
MYP_164645
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
25 amino acids
C150H203N41O39
Standard
Sequence
KQRQQLFDSQQGWFEGWFNRSPWFT
Physicochemical Analysis
3204.47 Da
8.75
0.76
0.56
0.0305
-1.33
0.34
-0.17
106.38
15.60
0.2800
16500.00
16500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1343.95
-11.45
46.0
40.0
101.0
230.0
11.0
30.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0116713 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 44.0%, C 56.0% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0384480 VERIFIED: YES
Provenance & Taxonomy
Feline leukemia virus [Virus]
Virus-derived peptide
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
Feline leukemia virus (Fusion); FEA
ELISA
PaperIn vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain. | Boenzli E, Robert-Tissot C, Sabatino G, Cattori V, Meli ML, Gutte B, Rovero P, Flynn N, Hofmann-Lehmann R, Lutz H. | Antivir Ther. 2011 | PMID:21900723 PMID21900723 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21900723/